# APBI Proton Feasibility and Phase II Study

> **NCT01839838** · PHASE1,PHASE2 · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 40 (actual)

## Conditions studied

- Stage IA-IIA Breast Cancer

## Interventions

- **RADIATION:** Proton Therapy

## Key facts

- **NCT ID:** NCT01839838
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-22
- **Primary completion:** 2022-12-23
- **Final completion:** 2022-12-23
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01839838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01839838, "APBI Proton Feasibility and Phase II Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01839838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*